60 results on '"Zolty, R."'
Search Results
2. Incidence of mTORi Associated BOOP in Cardiac Transplant Recipients – A Single Center Perspective.
3. Safety and Efficacy of SGLT2i Post Orthotopic Heart Transplantation.
4. The Impact of Evolocumab in Cardiac Transplant Patients with Coronary Allograft Vasculopathy.
5. Quality of life and prognosis in heart failure: results of the beta-blocker evaluation of survival trial (best)
6. (1087) - Oxydative Stress in Heart Failure Patients after Implantation of Continuous Flow Left Ventricular Assist Devices.
7. 838 Differences in Mortality and Morbidity in Pulmonary Hypertension Secondary to Systolic vs. Diastolic Heart Failure
8. 616 Bradykinin Targeted Therapy Decreases Mortality in Pulmonary Hypertension
9. 309 Mortality in Pulmonary Hypertension Stratified by Sedimentation Rate
10. 575: Hyponatremia on Admission Predicts Longer Length of Stay in Patients with Pulmonary Hypertension and Right Ventricular Failure
11. 435: Pulmonary Artery Hypertension: Endothelial Dysfunction and Statin Treatment
12. 436: Mortality and Readmission Rates in Hyponatremic Patients with Pulmonary Hypertension and Right Ventricular Failure
13. 49: Pulmonary Artery Hypertension: Heart Failure and ACE Inhibition
14. 47: Mortality and Readmission Rates with Dobutamine and Milrinone in Pulmonary Hypertension and Right Ventricular Failure
15. Combination of Axial Flow Circulatory Support and Aggressive Neurohormonal Blockade for Recovery of Cardiac Function in Advanced Heart Failure.
16. 573: Normalization of Fixed Pulmonary Hypertension in Severe Heart Failure Patients with Placement of Left Ventricular Assist Device
17. (856) - Enhancing Exercise Capacity in Exercise-Induced Pulmonary Hypertension: A Retrospective Study of Riociguat Therapy.
18. (448) - Exploring the Potential: GLP-1 Receptor Agonists for Advanced Therapies in End-Stage Heart Failure.
19. Recurrent Enteroviral Myocarditis in Transplanted Heart from Induced Immune Deficiency.
20. Endomyocardial Biopsy Microscopic Molecular Profiling Correlates with Donor Derived Cell Free DNA and Histopathology.
21. Sacubitril/Valsartan Improves Outcomes in Left Ventricular Assist Device Recipients.
22. Left Ventricular Internal Diastolic Diameter as a Predictor of Outcomes in Ischemic Cardiomyopathy.
23. Heart Failure with Preserved Ejection Fraction Induced Reactive Pulmonary Hypertension Lacks Nitric Oxide Vasoreactivity Similar to Pulmonary Arterial Hypertension.
24. First Results of Soprano: Macitentan in Patients (pts) with Pulmonary Hypertension (PH) Post-Left Ventricular Assist Device (LVAD) Implantation.
25. 678 Dose-Dependent Improvement in Survival with ACE Inhibitor Use in Patients with Pulmonary Arterial Hypertension and Heart Failure with Normal Ejection Fraction
26. 215 Higher Doses of Spirinolactone Are Associated with Lower Survival in Patients with Congestive Heart Failure
27. 214 Improved Survival with Sustained Release Metoprolol When Compared to Carvedilol in Patients with Ischemic Heart Failure: A Comparative Effectiveness Analysis
28. 504 Improved Survival with Pioglitazone in Patients with Diabetes Mellitus, Pulmonary Arterial Hypertension and Heart Failure with Normal Ejection Fraction: A Comparative Effectiveness Analysis
29. 288: Aldosterone Antagonism in Pulmonary Hypertension and Right Heart Failure
30. 332: Molecular Remodeling on Beta-Blocker Therapy in the Failing Human Heart
31. Reversible Cardiomyopathies—A Review
32. Impact of mTOR Inhibitor Conversion Protocol on Renal Function in Cardiac Transplant Recipients.
33. The Effect of Exercise on Endothelin 1 Level in Patients with Pulmonary Hypertension.
34. Trends in Exercise Capacity Following Heart Transplantation.
35. Pre-Operative Ventilatory Inefficiency is Associated with Gastrointestinal Bleeding in Patients with Continuous-Flow Left Ventricular Assist Devices.
36. Recurrent Pump Thrombosis is Common after Axial Continuous Flow LVAD Exchange.
37. Pre-Heart Transplant Spirometry Predicts Post-Transplant Survival.
38. Impact of Heart Rate and Left Ventricular Mass on Survival Following Heart Transplantation.
39. Comparison of Endothelin-1 Level in Group I Pulmonary Hypertension vs. Group II Pulmonary Hypertension Both at Rest and at Peak Exercise.
40. (778) - CMV Reactivation Using Valganciclovir vs Valacyclovir in Moderate Risk Heart Transplant Recipients.
41. (822) - Cardiac Allograft Sinus Tachycardia Is Associated with Impaired Exercise Tolerance.
42. (526) - Heart Rate and Cardiac Allograft Vasculopathy in Heart Transplant Recipients.
43. (748) - Heart Failure Patients’ Quality of Life and Perception of Palliative Care.
44. (1043) - Myocarditis Treated with VA-ECMO: A Single Centers Experience.
45. Mineralocorticoid Receptor Antagonists Enhance Cardiac Function during Continuous Flow Left Ventricular Assist Device Support.
46. Differentiating Heart Failure with Preserved Ejection Fraction Induced Pulmonary Hypertension from Pulmonary Hypertension Using Demographic Data and Common Blood Measurements.
47. Angiotensin-Converting Enzyme Inhibitors (ACEIs) or Angiotensin- Receptor Blockers (ARBs) during CF-LVAD Support Are Associated with Sustained Improvement in Renal Function.
48. Intracranial Hemorrhage Is Associated with a Higher Doppler Blood Pressure during Continuous Flow Left Ventricular Assist Device Support.
49. 833 Effect of Obesity on Mortality in Pulmonary Arterial Hypertension: A Retrospective Analysis
50. 621 Endothelin-1 Levels in Pulmonary Hypertension: A Comparison between Pulmonary Arterial Hypertension and Diastolic Heart Failure-Induced Pulmonary Hypertension
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.